Canlyniadau Chwilio - GIRNITA, Ada

Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptor gan Girnita, Leonard, Girnita, Ada, Larsson, Olle

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Targeting the IGF-1R: The Tale of the Tortoise and the Hare gan Crudden, Caitrin, Girnita, Ada, Girnita, Leonard

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Personalized Medicine in Malignant Melanoma: Towards Patient Tailored Treatment gan Helgadottir, Hildur, Rocha Trocoli Drakensjö, Iara, Girnita, Ada

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Differences in cutaneous melanoma treatment and patient satisfaction gan Wikstrom, Jakob D., Lundeberg, Lena, Frohm-Nilsson, Margareta, Girnita, Ada

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Correction: Differences in cutaneous melanoma treatment and patient satisfaction gan Wikstrom, Jakob D., Lundeberg, Lena, Frohm-Nilsson, Margareta, Girnita, Ada

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Ten-year Follow-up Study of Grenz Ray Treatment for Lentigo Maligna and Early Lentigo Maligna Melanoma gan DRAKENSJÖ, Iara R. T., ROSEN, Einar, FROHM NILSSON, Margareta, GIRNITA, Ada

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulation gan Girnita, Leonard, Worrall, Claire, Takahashi, Shin-Ichiro, Seregard, Stefan, Girnita, Ada

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Enhanced response of melanoma cells to MEK inhibitors following unbiased IGF-1R down-regulation gan Suleymanova, Naida, Crudden, Caitrin, Worrall, Claire, Dricu, Anica, Girnita, Ada, Girnita, Leonard

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Selective recruitment of G protein-coupled receptor kinases (GRKs) controls signaling of the insulin-like growth factor 1 receptor gan Zheng, Huiyuan, Worrall, Claire, Shen, Hongchang, Issad, Tarik, Seregard, Stefan, Girnita, Ada, Girnita, Leonard

Cael y testun llawn Cael y testun llawn Cael y testun llawn

β-Arrestin–biased agonism as the central mechanism of action for insulin-like growth factor 1 receptor–targeting antibodies in Ewing’s sarcoma gan Zheng, Huiyuan, Shen, Hongchang, Oprea, Iulian, Worrall, Claire, Stefanescu, Radu, Girnita, Ada, Girnita, Leonard

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Below the Surface: IGF-1R Therapeutic Targeting and Its Endocytic Journey gan Crudden, Caitrin, Song, Dawei, Cismas, Sonia, Trocmé, Eric, Pasca, Sylvya, Calin, George A., Girnita, Ada, Girnita, Leonard

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Targeting the insulin-like growth factor-1 receptor by picropodophyllin as a treatment option for glioblastoma gan Yin, Shucheng, Girnita, Ada, Strömberg, Thomas, Khan, Zahidul, Andersson, Sandra, Zheng, Huiyuan, Ericsson, Christer, Axelson, Magnus, Nistér, Monica, Larsson, Olle, Ekström, Tomas J., Girnita, Leonard

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Bullous Pemphigoid-like Eruption Triggered by Targeted Therapy for Metastatic Melanoma gan ERIKSSON, Hanna, HANSSON, Johan, KRYNITZ, Britta, MASUCCI, Giuseppe, GIRNITA, Ada, LAPINS, Jan, HUEN, Auris O., TAWBI, Hussein A., DAVIES, Michael A., TETZLAFF, Michael T., CURRY, Jonathan L.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

IRS-2 deubiquitination by USP9X maintains anchorage-independent cell growth via Erk1/2 activation in prostate carcinoma cell line gan Furuta, Haruka, Yoshihara, Hidehito, Fukushima, Toshiaki, Yoneyama, Yosuke, Ito, Akihiro, Worrall, Claire, Girnita, Ada, Girnita, Leonard, Yoshida, Minoru, Asano, Tomoichiro, Komada, Masayuki, Kataoka, Naoyuki, Chida, Kazuhiro, Hakuno, Fumihiko, Takahashi, Shin-Ichiro

Cael y testun llawn Cael y testun llawn Cael y testun llawn